Data / Public companies / Commercial physical and biological research
Commercial physical and biological research (SIC 8731): 17 companies that file annual reports with the SEC
Updated September 30, 2026. Source: SEC Financial Statement Data Sets (sec.gov).
17 companies that file annual reports with the SEC have the industry code SIC 8731 (Commercial physical and biological research), in the data filed through September 30, 2026. 15 report revenue, a combined $36.98 billion, with a median of $33.0 million. 29.4% of the 17 that report net income show a profit. The largest by revenue is Iqvia Holdings Inc. ($16.31 billion).
The request: Get every company that files with the SEC in the industry Commercial physical and biological research (SIC 8731), with its revenue, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.
- SIC code
- 8731
- SEC industry title
- Services-Commercial Physical & Biological Research
- Division
- Services
- Companies with an annual report in the data
- 17
- Companies that report revenue
- 15
- Combined revenue
- $36.98 billion
- Median revenue
- $33.0 million
- Reported a net profit
- 5 of 17 (29.4%)
- Combined total assets
- $63.98 billion
- Large accelerated filers
- 5
- Newest annual report filed
- June 17, 2026
Largest by revenue
Latest fiscal year, from each company's annual report. Each name links to the company's page.
| Company | Business address | Revenue | Net income | Total assets | Revenue change |
|---|---|---|---|---|---|
| Iqvia Holdings Inc. | Durham, NC | $16.31 billion | $1.36 billion | $29.94 billion | 5.9% |
| Icon PLC | Dublin 18, Ireland | $8.25 billion | $229.3 million | $16.27 billion | 0.8% |
| Incyte Corp | Wilmington, DE | $5.14 billion | $1.29 billion | $6.96 billion | 21.2% |
| Charles River Laboratories International, Inc. | Wilmington, MA | $4.02 billion | $-144,338,000 | $7.14 billion | -0.9% |
| Medpace Holdings, Inc. | Cincinnati, OH | $2.53 billion | $451.1 million | $1.98 billion | 20% |
| Inotiv, Inc. | West Lafayette, IN | $513 million | $-68,625,000 | $771.1 million | 4.5% |
| National Research Corp | Lincoln, NE | $137.4 million | $11.6 million | $134.9 million | -4% |
| Maxcyte, Inc. | Rockville, MD | $33 million | $-44,630,000 | $202.5 million | -14.5% |
| Omniab, Inc. | Emeryville, CA | $18.7 million | $-64,779,000 | $300.9 million | -29.3% |
| Foxo Technologies Inc. | West Palm Beach, FL | $16.4 million | $-12,430,390 | $44.6 million | 304% |
| Bioaffinity Technologies, Inc. | San Antonio, TX | $6.2 million | $-14,909,754 | $11 million | -34.2% |
| Absci Corp | Vancouver, WA | $2.8 million | $-115,183,000 | $216.3 million | -38.2% |
| Ispecimen Inc. | Woburn, MA | $1.9 million | $-10,487,532 | $9.5 million | -79.2% |
| Onemednet Corp | Surrey, United Kingdom | $1.4 million | $-2,801,000 | $2.2 million | 111.4% |
| Cannabis Bioscience International Holdings, Inc. | Houston, TX | $303,022 | $-548,820 | $31,880 | 21.8% |
Companies by size of revenue
Companies that report revenue, by the revenue in their latest annual report.
| Revenue | Companies | Share |
|---|---|---|
| Under $10 million | 5 | 33.3% |
| $10 million to $100 million | 3 | 20% |
| $100 million to $1 billion | 2 | 13.3% |
| $1 billion to $10 billion | 4 | 26.7% |
| $10 billion and over | 1 | 6.7% |
States with the most companies
By state of the business address.
| State | Companies | Share | Combined revenue |
|---|---|---|---|
| California | 2 | 11.8% | $18.7 million |
| Massachusetts | 2 | 11.8% | $4.02 billion |
| Texas | 2 | 11.8% | $6.5 million |
| Arizona | 1 | 5.9% | $0 |
| Delaware | 1 | 5.9% | $5.14 billion |
| Florida | 1 | 5.9% | $16.4 million |
| Indiana | 1 | 5.9% | $513 million |
| Maryland | 1 | 5.9% | $33 million |
| North Carolina | 1 | 5.9% | $16.31 billion |
| Nebraska | 1 | 5.9% | $137.4 million |
| Ohio | 1 | 5.9% | $2.53 billion |
| Washington | 1 | 5.9% | $2.8 million |
Newest annual reports
By the date the company filed its latest annual report with the SEC.
| Company | Filed | Fiscal year ended | Form | Revenue |
|---|---|---|---|---|
| Vitaspring Biomedical Co. LTD. | June 17, 2026 | January 31, 2026 | 10-K | $0 |
| Icon PLC | May 27, 2026 | December 31, 2025 | 20-F | $8.25 billion |
| Foxo Technologies Inc. | April 15, 2026 | December 31, 2025 | 10-K | $16.4 million |
| Weed, Inc. | April 8, 2026 | December 31, 2025 | 10-K | $0 |
| Ispecimen Inc. | April 1, 2026 | December 31, 2025 | 10-K | $1.9 million |
| Onemednet Corp | March 30, 2026 | December 31, 2025 | 10-K | $1.4 million |
| Maxcyte, Inc. | March 25, 2026 | December 31, 2025 | 10-K | $33 million |
| Absci Corp | March 24, 2026 | December 31, 2025 | 10-K | $2.8 million |
| Bioaffinity Technologies, Inc. | March 16, 2026 | December 31, 2025 | 10-K | $6.2 million |
| National Research Corp | March 5, 2026 | December 31, 2025 | 10-K | $137.4 million |
| Omniab, Inc. | March 4, 2026 | December 31, 2025 | 10-K | $18.7 million |
| Charles River Laboratories International, Inc. | February 18, 2026 | December 31, 2025 | 10-K | $4.02 billion |
Filer category
The SEC's size class for the company when it filed.
| Category | Companies | Share |
|---|---|---|
| Non-accelerated filer | 10 | 58.8% |
| Large accelerated filer | 5 | 29.4% |
| Accelerated filer | 2 | 11.8% |
Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.